Genetic Test Can Identify Triple Negative Breast Cancer Treatment

A test including 53 genes can predict who will respond and who will not respond to triple negative breast cancer immunotherapy.

Hereditary Breast Cancer

Inside Precision Medicine on LinkedIn: Researchers Identify 17 Variants Associated with Alzheimer's Disease

Cervical Cancer Outcomes Boosted by Induction Chemotherapy

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Inside Precision Medicine

Can Immunotherapy be Democratized?

Cancers, Free Full-Text

Triple Negative Breast Cancer - National Breast Cancer Foundation

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy - ScienceDirect

New Test for HER2-Low Expression Could Expand Treatment Options

Big Data Analysis Identifies Drivers of Immune Response to Cancer

Can Immunotherapy be Democratized?